OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 31, 2023
The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation.
August 29, 2023
Danaher intends to acquire Abcam, a provider of life sciences assays and reagents, for $5.7 billion.
August 15, 2023
The completion of three acquisitions of Versanis Bio, Sigilon Therapeutics, and DICE Therapeutics boosts Eli Lilly and Company’s product pipeline in obesity, diabetes, and immunology.
August 11, 2023
Novartis has completed its acquisition of biopharma company Chinook Therapeutics.
August 01, 2023
Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.
July 21, 2023
The proposed spin-off of Sandoz into an independent entity has been approved by Novartis’ board of directors.
July 20, 2023
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.
June 08, 2023
The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.
May 24, 2023
UK government supports AMR research with significant cash injection, provided through the Global AMR Innovation Fund (GAMRIF).
May 18, 2023
Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.